2026 Global: Capsule Endoscopy Market -Competitive Review (2032) report
Description
The 2026 Global: Capsule Endoscopy Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
The capsule endoscopy market is dominated by ten major companies that collectively drive innovation and market growth in gastrointestinal diagnostic technology. CapsoVision, headquartered in California, United States, leads the sector as a developer of wireless capsule endoscopy solutions featuring 360° panoramic imaging capabilities. The company received FDA clearance in January 2025 for CapsoCam Plus pediatric use. IntroMedic, based in Seoul, South Korea, established in 2004, represents a significant player in smart pills technology and capsule endoscopy systems. Medtronic, headquartered in Dublin, Ireland, commands substantial market presence through its extensive Medical Surgical portfolio, generating USD 8.4 billion in net sales for fiscal year 2024. Olympus Corporation, located in Tokyo, Japan and established in 1919, maintains leadership in gastrointestinal endoscopic equipment with advanced imaging technologies including narrow band imaging and high-definition visualization. Jinshan Science & Technology (Group), headquartered in Chongqing, China, represents a major Asia-Pacific player in the capsule endoscopy market.
Check-Cap, based in Haifa, Israel and established in 2004, contributes significant technological advancement to the market. AnX Robotica, located in Plano, Texas, United States, developed the NaviCam capsule endoscopy equipment utilized in the first U.S. study of magnetically controlled capsule endoscopy conducted at George Washington University in 2023. RF System Lab operates as a key market participant, though specific headquarters information is not detailed in available sources. Shangxian Minimal Invasive Inc., based in China, rounds out the ten major companies and focuses on capsule endoscopy innovation.
These companies collectively demonstrate consistent focus on product innovation, particularly in imaging quality enhancement, battery life extension, and artificial intelligence integration for improved diagnostics. The market remains highly consolidated, with the two largest players—Medtronic and Olympus Corporation—collectively holding 85-90% of total market share according to 2025 data. Recent significant developments include CapsoVision's November 2025 FDA application for Breakthrough Device Designation for a new capsule endoscopy variant aimed at early-stage pancreatic cancer screening, expanding diagnostic applications beyond small-bowel imaging into broader gastrointestinal oncology. Boston Scientific, another major medtech company, opened its first Chinese manufacturing facility in Shanghai's Lingang Free Trade Zone in 2023 to serve the Chinese market. These companies maintain strong global presence through distribution networks spanning North America, Europe, Asia-Pacific, and the Middle East, establishing partnerships with leading medical device distributors and healthcare providers worldwide.
The capsule endoscopy market is dominated by ten major companies that collectively drive innovation and market growth in gastrointestinal diagnostic technology. CapsoVision, headquartered in California, United States, leads the sector as a developer of wireless capsule endoscopy solutions featuring 360° panoramic imaging capabilities. The company received FDA clearance in January 2025 for CapsoCam Plus pediatric use. IntroMedic, based in Seoul, South Korea, established in 2004, represents a significant player in smart pills technology and capsule endoscopy systems. Medtronic, headquartered in Dublin, Ireland, commands substantial market presence through its extensive Medical Surgical portfolio, generating USD 8.4 billion in net sales for fiscal year 2024. Olympus Corporation, located in Tokyo, Japan and established in 1919, maintains leadership in gastrointestinal endoscopic equipment with advanced imaging technologies including narrow band imaging and high-definition visualization. Jinshan Science & Technology (Group), headquartered in Chongqing, China, represents a major Asia-Pacific player in the capsule endoscopy market.
Check-Cap, based in Haifa, Israel and established in 2004, contributes significant technological advancement to the market. AnX Robotica, located in Plano, Texas, United States, developed the NaviCam capsule endoscopy equipment utilized in the first U.S. study of magnetically controlled capsule endoscopy conducted at George Washington University in 2023. RF System Lab operates as a key market participant, though specific headquarters information is not detailed in available sources. Shangxian Minimal Invasive Inc., based in China, rounds out the ten major companies and focuses on capsule endoscopy innovation.
These companies collectively demonstrate consistent focus on product innovation, particularly in imaging quality enhancement, battery life extension, and artificial intelligence integration for improved diagnostics. The market remains highly consolidated, with the two largest players—Medtronic and Olympus Corporation—collectively holding 85-90% of total market share according to 2025 data. Recent significant developments include CapsoVision's November 2025 FDA application for Breakthrough Device Designation for a new capsule endoscopy variant aimed at early-stage pancreatic cancer screening, expanding diagnostic applications beyond small-bowel imaging into broader gastrointestinal oncology. Boston Scientific, another major medtech company, opened its first Chinese manufacturing facility in Shanghai's Lingang Free Trade Zone in 2023 to serve the Chinese market. These companies maintain strong global presence through distribution networks spanning North America, Europe, Asia-Pacific, and the Middle East, establishing partnerships with leading medical device distributors and healthcare providers worldwide.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
